Ameriprise Financial Inc Amgen Inc Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Amgen Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,943,963 shares of AMGN stock, worth $614 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,943,963

Previous 1,974,597 1.55%

Holding current value

$614 Million

Previous $561 Million 8.19%

% of portfolio

0.17%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $8.05 Million - $9.78 Million	-30,634 Reduced 1.55%	1,943,963 $607 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $51.7 Million - $62.4 Million	-192,288 Reduced 8.87%	1,974,597 $561 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $10.1 Million - $11.4 Million	39,417 Added 1.85%	2,166,885 $624 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $17.9 Million - $22.2 Million	81,655 Added 3.99%	2,127,468 $572 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $43 Million - $50.9 Million	200,755 Added 10.88%	2,045,813 $454 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $13.6 Million - $16.6 Million	-60,428 Reduced 3.17%	1,845,058 $446 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $62.3 Million - $79.1 Million	271,833 Added 16.64%	1,905,486 $500 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $10.4 Million - $11.7 Million	-46,113 Reduced 2.75%	1,633,653 $370 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $18.6 Million - $20.7 Million	-80,744 Reduced 4.59%	1,679,766 $408 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $10.7 Million - $11.8 Million	-48,667 Reduced 2.69%	1,760,510 $417 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $104 Million - $119 Million	523,894 Added 40.76%	1,809,177 $397 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $37.4 Million - $43.9 Million	-176,347 Reduced 12.07%	1,285,283 $272 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $4.39 Million - $4.87 Million	18,811 Added 1.3%	1,461,630 $355 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $15 Million - $17.4 Million	67,404 Added 4.9%	1,442,819 $359 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $47.4 Million - $56.4 Million	-219,017 Reduced 13.74%	1,375,415 $316 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $16.5 Million - $18.3 Million	70,268 Added 4.61%	1,594,432 $406 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $52.8 Million - $64.8 Million	-267,020 Reduced 14.91%	1,524,164 $360 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $26 Million - $34.5 Million	-142,842 Reduced 7.39%	1,791,184 $364 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $54.8 Million - $70.4 Million	289,519 Added 17.61%	1,934,026 $468 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $25.3 Million - $30.3 Million	-145,432 Reduced 8.12%	1,644,507 $319 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $18.6 Million - $21.8 Million	-111,307 Reduced 5.85%	1,789,939 $330 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $32.7 Million - $36.9 Million	180,926 Added 10.52%	1,901,246 $361 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $3.71 Million - $4.33 Million	20,781 Added 1.22%	1,720,320 $336 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $859,375 - $968,831	4,638 Added 0.27%	1,699,539 $397 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $2.36 Million - $2.65 Million	-14,217 Reduced 0.83%	1,694,901 $314 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $12.3 Million - $14.3 Million	-72,383 Reduced 4.06%	1,709,118 $291 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $31 Million - $34.7 Million	-183,907 Reduced 9.36%	1,781,501 $309 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $329 Million - $375 Million	1,965,408	1,965,408 $367 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Amgen Inc Transaction History